So far, PTX3 level has been proposed as a risk predictor for acute myocardial infarction [5] and biomarker of adverse outcome in patients with unstable angina pectoris [25], myocardial infarction [9] and heart failure [10]. The gene discussed is PTX3; the disease is intermediate coronary syndrome.